# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-065652
Filing Date
2025-05-07
Accepted
2025-05-07 16:09:31
Documents
92
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cprx-20250331.htm iXBRL | 10-Q | 2019138
2 | EX-31.1 | cprx-ex31_1.htm | EX-31.1 | 14555
3 | EX-31.2 | cprx-ex31_2.htm | EX-31.2 | 14564
4 | EX-32.1 | cprx-ex32_1.htm | EX-32.1 | 10956
5 | EX-32.2 | cprx-ex32_2.htm | EX-32.2 | 10971
| Complete submission text file | 0000950170-25-065652.txt |  | 10298517

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | cprx-20250331.xsd | EX-101.SCH | 1359556
95 | EXTRACTED XBRL INSTANCE DOCUMENT | cprx-20250331_htm.xml | XML | 2078793

Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 25921405
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)